(Date:12/1/2009)... , SAN DIEGO, Dec. 1 /PRNewswire-FirstC... AEMD) announced today that it will present at the... at 2:00 p.m. (PST) at the Luxe Hotel in Los Angel...oyce, will present a corporate overview and will p...s for its lead product, the Hemopurifier®, a ...
(Date:12/1/2009)... , INDIANAPOLIS and NORTH VANCOUVER, British Co...ciences LLC, a wholly owned subsidiary of The Dow ...ciences, Inc. today announced the signing of a res... agreement provides Dow AgroSciences with access t...L) technology on an exclusive basis in major food ...
(Date:12/1/2009)... , SAN FRANCISCO, Dec. 1 /PRNewswire-FirstCall/...rd: MZEI) announced today that in tests involving ...tinues to break "6 log" decontamination barriers, ...cteria, Claustridium difficile and Bacillis subtil...) as an extremely potent sporicidal technology. "T...
(Date:12/1/2009)... , ATLANTA, Dec. 1 ... "Company"), an Atlanta-based, biopharmaceutical c...ed by HIV-1 (Human Immunodeficiency Virus) and oth...for World AIDS Day. ,, "Today is the 21st World...e lost their fight with the HIV/AIDS pandemic, we ...
Breaking Biology Technology:Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6...Calif., Feb. 9 Beckman Coulter, Inc. (NYSE: BEC...er of products that simplify, automate and innovat...th quarter and year ended December 31, 2008 result....3 million, up 2.8%, on robust sales to Clinical D...e in Life Sciences revenue. In constant currency,...
...Calif., Feb. 9 Beckman Coulter, Inc. (NYSE: BEC...lared a quarterly dividend payout of seventeen cen...payable on March 6, 2009 to all stockholders of re... the 79th consecutive, quarterly payout of dividen...rnh/20031202/BECLOGO ) , , Beckman Coulter, Inc.,...
... M2S Inc., a global provider of image man... device clinical trials, announced today that the ...ss how state-of-the-art image management can enhan...assurance services for bone mineral density trials...sition measurements with DXA. , ...
Other Biology Technology:Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 2Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 3Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 4Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 5Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 6Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 7Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 8Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 9Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 10Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 11Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 12Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 13Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 14Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 15Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 16Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 17Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 18Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 19Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 20Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 21Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 22Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 23Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 24Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 25Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 26Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 27Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 28Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 29Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 30Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 31Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 32Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals 33Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert 2Factor Xa Protease from QIAGEN
Mung Bean Nuclease from New England Biolabs
...s for interferons are cytopathic effect inhibition...Sample types include; tissue culture supernatents;... In these assays, one unit is defined as the quant...e the cytopathic effect of viral infection by 50%....
SP6 RNA Polymerase from Roche Applied Science
Biology Products: